Navigation Links
Press statement on new CDC MRSA study from SHEA president
Date:2/17/2009

A new study from the Centers for Disease Control and Prevention (CDC) shows a decrease in catheter-associated bloodstream infections caused by both methicillin-resistant and methicillin-sensitive S. aureus. The 10-year national study, 'Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997,' reported data from both the National Nosocomial Infection Surveillance (NNIS) and its successor, the National Healthcare Safety Network (NHSN). The study demonstrates a steady decline in intensive care unit catheter-associated MRSA bloodstream infections since 2001.

Below Are Quotes from Mark Rupp, MD, President of SHEA

"Despite the fact that MRSA prevalence continues to rise, efforts to prevent catheter infections are paying dividends and the number of infections due to all types of Staphylococcus aureus, including MRSA, have been falling sharply since 2001. Therefore, simply examining the percentage of staphylococcal isolates that are MRSA can be a misleading indicator of the burden of disease caused by this organism."

"The rate of these infections is decreasing and hospitals are becoming safer for patients because hospitals are instituting and adhering to general practices that result in fewer infections, including measures to ensure proper catheter insertion and removal, hand hygiene, environmental cleanliness, and antimicrobial stewardship.

"Because MRSA only causes about 8% of healthcare-associated infections, it is critical that we not concentrate all of our preventive efforts on a single bacterium. Undue emphasis on a single organism like MRSA can dilute broader-based measures that can have a dramatic effect on infections caused by many different organisms.

"This study illustrates that it is more important for hospitals to focus on the infections and diseases that the germs cause rather than the germs themselves. Decreasing the infections will decrease the burden of disease caused by all resistant organisms and not just MRSA."


'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
GYMR
Source:Eurekalert

Related biology news :

1. Molecule that suppresses immune response under study in type 1 diabetes
2. UNC study: Tinkering with the circadian clock can suppress cancer growth
3. Pregnancy hormone predicts postpartum depression
4. American Chemical Societys Weekly PressPac -- Jan. 28, 2009
5. DNA component can stimulate and suppress the immune response
6. Cutting salt isnt the only way to reduce blood pressure
7. American Chemical Societys weekly PressPac -- Jan. 14, 2009
8. American Chemical Societys Weekly PressPac -- Jan. 7, 2009
9. Facial expressions of emotion are innate, not learned, says new study
10. Krumlauf Lab demonstrates modulation of gene expression by protein coding regions
11. American Chemical Societys Weekly PressPac -- Dec. 17, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... 2017   Bridge Patient Portal , an ... MD EMR Systems , an electronic medical record ... have established a partnership to build an interface ... GE Centricity™ products, including Centricity Practice Solution (CPS), ... These new integrations will allow healthcare delivery networks ...
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... compared the implantation and pregnancy rates in frozen and fresh in vitro ... of progesterone and maternal age to IVF success. , After comparing the results ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... International research firm Parks Associates announced today that Tom ... 2017 Annual Meeting , October 11 in Scottsdale, Arizona ... and how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... year’s recipients of 13 prestigious awards honoring scientists who have ... presented in a scheduled symposium during Pittcon 2018, the world’s leading conference and ...
Breaking Biology Technology: